Earlier this year, Florida-based GenesisCare successfully emerged from Chapter 11 reorganization. The integrated oncology and multispecialty physician network provides care for more than 120,000 patients in Florida and North Carolina with a catchment area largely in underserved areas. With a much slimmer footprint and independence from its global parent organization, the company has a better market position and the ground strength to grow as it follows its mission to redefine the care experience by improving patient outcomes, access, and care delivery.
Rebranded as GenesisCare U.S., it is no longer affiliated with units in Australia, Spain, and the U.K. With 160 sites across the two states, the system offers comprehensive and coordinated care in radiation oncology, medical oncology, hematology, urology, diagnostics, ENT, and surgical oncology.
In 2020, when Michael McKenna joined as the head of U.S. procurement, he reported to the Australian business unit, but plans to adopt global strategies didn’t necessarily scale. “The specifics of the U.S. healthcare market, with its regulatory frameworks and complex reimbursement models, as well as market variability across 17 states presented high implementation hurdles,” he explained.
